algovita sale in-lin
sale in-lin pre-announce report algovita
sale report total sale
report excl neuronexu revenu in-lin
pre-announce loss per share lp better
estim consensu gm
forecast consensu opex
lower our/consensu estim
outlook compani give guidanc full year
sales/lp estim cc vs
consensu
look call progress ceo transit
potenti strategi chang cost-effect drive market share
gain spinal cord stimul sacral nerv stimul market
link commentari rational chang algovita
sale momentum us futur driver competit gain given new
system launch buy buy
well nr commit provid flexibl system
progress algovita salesforc develop matur commentari
us market slowdown outlook submiss time fda
full bodi mr-condit label algovita expect submit
updat virti us approv time inclus whether clinic data
need sinc compani announc fda extend
review period link perceiv competit virti rel
axon buy offer year life full-bodi mri label
like excel clinic data size virti go-to-market salesforc
updat regard european virti strategi enrol progress
hi-fi arm post-market clinic studi full enrol expect
detail addit waveform stimul arm inclus long puls
nvtr earn call februari pm et dial-in
page
actualstrh estimatesconsensu actual vs consensu statement actualstrh estimatesconsensu actual vs consensu expens expens incom actualstrh estimatesconsensu actual vs consensusmargin nuvectra corpor
valuat risk
price target arriv appli ev/sal multipl nvtr total revenu
ev/sal multipl conserv average/median forward multipl
seen amongst peer group faster grow smid med-tech compani
accommod hypothet scenario assum virti revenu contribut would requir
ev/sal multipl still discount peer maintain valuat risk includ
lower penetr sn model failur achiev sn and/or mri
approv time manner excess spend build scs/sn salesforc result
dilut anticip
compani mention note
bruce nudel herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
suntrust robinson humphrey inc affili manag co-manag secur offer
follow compani within last month nvtr-u
suntrust robinson humphrey inc make market follow compani nvtr-u
follow compani client suntrust robinson humphrey inc invest bank servic
within last month nvtr-u
suntrust robinson humphrey inc affili receiv compens invest bank
servic within last month nvtr-u
analyst compens base upon stock price perform qualiti analysi commun skill
overal revenu profit firm includ invest bank revenu
matter polici practic firm prohibit offer favor research specif
research rate specif target price consider induc receipt busi
compens addit associ person prepar research report prohibit own
secur subject compani
rate price target histori nuvectra corpor nvtr-u
strh rate system equiti secur
dissemin research
creat bluematrix
page
suntrust robinson humphrey strh seek make reason effort provid research report
simultan elig client report avail publish restrict access area
websit elig client request password institut investor corpor
member press may also receiv research via third parti vendor includ thomson reuter
bloomberg factset capit iq addit distribut may done sale personnel via
email fax electron mean regular mail
access third parti vendor research websit http //suntrustlibrari bluematrix com/client/
pleas email research depart
contact strh sale repres
rate system effect oct
strh rate equiti secur
rate rel broader market gener next month unless
buy stock total return expect outperform relev benchmark
hold stock total return expect perform line relev benchmark
next month unless otherwis indic
sell stock total return expect under-perform relev benchmark
next month unless otherwis indic
rate nr strh invest rate opinion stock
coverag suspend cs indic strh rate and/or target price temporarili
suspend due applic regul and/or strh manag discret previous publish
rate target price reli upon
strh analyst price target stock cover unless otherwis indic price
target repres analyst expect stock trade next month unless
otherwis indic analyst believ insuffici valuat driver and/or invest
catalyst deriv posit neg invest view may elect approv strh
research manag assign target price likewis certain stock trade may
exhibit volatil wherebi assign price target would unhelp make invest decis
research manag approv analyst may refrain assign target sub-
legend rate price target histori chart
prior rate system oct
design base total return within period
buy total return low-beta secur
reduc total return neg low beta secur
neutral total return within bound
nr rate strh provid equiti research coverag
page
total return price appreci dividend price target within period unless
otherwis note beta defin secur averag beta less use bloomberg
suntrust robinson humphrey rate distribut
